CF PharmTech, Inc. (HKG:2652)
Hong Kong · Delayed Price · Currency is HKD 11.00
+0.37 (3.48%)
Sep 18, 2026, 4:08 PM HKT
CF PharmTech Revenue
CF PharmTech had revenue of 105.08M CNY in the quarter ending June 30, 2026, a decrease of -24.82%. This brings the company's revenue in the last twelve months to 436.80M, down -27.67% year-over-year. In the year 2025, CF PharmTech had annual revenue of 432.52M, down -28.83%.
Revenue (ttm)
436.80M CNY
Revenue Growth
-27.67%
P/S Ratio
8.86
Revenue / Employee
698.87K CNY
Employees
625
Market Cap
4.47B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 432.52M | -175.23M | -28.83% |
| Dec 31, 2024 | 607.75M | 51.33M | 9.23% |
| Dec 31, 2023 | 556.42M | 207.29M | 59.37% |
| Dec 31, 2022 | 349.13M | 307.14M | 731.54% |
| Dec 31, 2021 | 41.99M | 37.13M | 764.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.